FILE: President Abdel Fatah al-Sisi
CAIRO – 28 August 2019: President Abdel Fatah al-Sisi approved Wednesday the establishment of an authority to monitor unified drug procurement, medical supply and medical technology management along with the Egyptian Pharmaceutical Authority.
The new bodies are alternatives to the General Authority for Pharmaceutical Research and Control and the National Authority for Research and Control of Biopharmaceuticals.
The establishment of these authorities aims at developing the health system and medical industries, providing medication on a regular basis, countering monopolistic practices in the medical sector,and fighting the phenomenon of counterfeit medicines.
According to the law, the Egyptian Drug Authority is a public service body affiliated to the prime minister. The establishment of a main headquarters is also to be determined the prime minister.
The law states that the Egyptian Drug Authority replaces the National Authority for Drug Control and Research established by the Presidential Decree No. 382 of 1976 and the National Commission for Research and Control of Biologics established by Presidential Decree No. 398 of 1995 and other bodies.
Furthermore, the law stipulates that the Egyptian Medicine Authority replaces the Ministry of Health and Population and the chairman of its board of directors replaces the minister of health and population in the specialties stipulated in Law No. 127 of 1955 regarding practicing the pharmacy profession, regulating the registration, as well as handling and controlling medical preparations and supplies.
Additional reporting by Walaa Ali
Comments
Leave a Comment